MedPath

The effect of memantine in the treatment of optic neuritis

Not Applicable
Conditions
Optin Neuritis.
neuropathy, except ischaemic
Registration Number
IRCT2017042633647N1
Lead Sponsor
Vice chancellor for research, Tehran University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Male
Target Recruitment
64
Inclusion Criteria

age range 18 to 46 years; the first attack of acute optic neuritis with visual symptoms of 8 days duration or less .
Exclusion criteria: lack of diagnostic criteria of multiple sclerosis; negative history of immunosuppressive drugs ; no history of ophthalmic problems or surgery.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Visual Acuity. Timepoint: Start of study, 3 Month after treatment. Method of measurement: Snelen chart.
Secondary Outcome Measures
NameTimeMethod
Visual Evoked Potential. Timepoint: Start of Study, 3 Month after treatment. Method of measurement: with Visual Evoked Potential instrument.
© Copyright 2025. All Rights Reserved by MedPath